Suicide attempts, platelet monoamine oxidase and the average evoked response

Acta Psychiatrica Scandinavica

Volumn 56, Issue 1, 1977, Pages 69-79

  Buchsbaum, M S ^a   Haier, R J ^a   Murphy, D L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

average evoked response; Platelet monoamine oxidase; suicide; visual evoked potential

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING);

AFFECTIVE NEUROSIS; EVOKED VISUAL RESPONSE; GENETICS; MAJOR CLINICAL STUDY; SUICIDE ATTEMPT; THEORETICAL STUDY; THROMBOCYTE;

ADULT; AFFECTIVE SYMPTOMS; BLOOD PLATELETS; CLINICAL TRIALS; FEMALE; HUMAN; MALE; MIDDLE AGE; MONOAMINE OXIDASE; SUICIDE, ATTEMPTED;

EID: 0017692598     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1977.tb06665.x     Document Type: Article

References (48)

1. Prognostic survey of discharged schizophrenic patients: Medication and social life of schizophrenics at the time of survey
2. “Serotonin depression”— A biochemical subgroup within the affective disorders
3. A hundred cases of suicide: Clinical aspects
4. Noradrenaline, 5‐hydroxytryptamine, and 5‐hydroxyindoleacetic acid in hindbrains of suicidal patients
5. CSF acid monoamine metabolites as a possible reflection of central MAO activity in chronic schizophrenia
6. Average evoked response augmenting/reducing in schizophrenia and affective disorders
7. Self‐regulation of stimulus intensity: Augmenting/reducing and the average evoked response
8. The biochemical high‐risk paradigm: Behavioral and familial correlates of low platelet monoamine oxidase activity
9. Average evoked response in bipolar and unipolar affective disorders: Relationship to sex, age of onset and monoamine oxidase
10. Suicide, diagnosis and age
11. Todesgedanken, Suicide und Suicidversuche im Verlauf kindlicher Schizophrenien
12. Brain‐levels of monoamine oxidase in depression
13. Lowered monoamine oxidase activity in brains from alcoholic suicides
14. Aetiological factors in attempted suicide
15. A study of selected catecholamine metabolizing enzymes: A comparison of depressive suicides and alcoholic suicides with controls
16. Eye‐tracking patterns in schizophrenia
17. Attempted suicides in adolescence
18. The types and prevalence of mental illness in the biological and adoptive families of adopted schizophrenics
19. Schizophrenia and stimulus intensity control
20. Reduced platelet monoamine oxidase activity in first degree relatives of individuals with bipolar affective disorders: A preliminary report
21. Neuromuscular dysfunction in schizophrenia
22. Biogenic amine‐related enzymes and personality variations in normals
23. Monoamine oxidase in schizophrenia and other behavioral disorders
24. Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients
25. Platelet and plasma amine oxidase activity in 680 normals: Sex and age differences and stability over time
26. Neurotransmitter‐related enzymes in the major psychiatric disorders: I. Catechol‐O‐methyl transferase, monoamine oxidase in the affective disorders, and factors affecting some behaviorally correlated enzyme activities
27. 5‐hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal‐gas poisoning
28. Mortality, suicide and life‐cycles
29. Suicide rates in various psychiatric disorders
30. Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides
31. A ten‐year follow‐up of children of schizophrenic mothers: Clinical assessment
32. Multiple forms of monoamine oxidase in brain: A comparison of enzymatic activity in mentally normal and chronic schizophrenic individuals
33. Suicide in childhood and early adolescence.
34. 5‐hydroxytryptamine in the hindbrain of depressive suicides
35. Sex differences in perceptual differentiation and stimulus intensity control
36. Evoked potential tests of augmenting‐reducing
37. Clinical criteria for psychiatric diagnmis and DSM‐111
38. Adolescent suicidal behavior
39. The Iowa 500: Suicide in mania, depression, and schizophrenia
40. Low platelet monoamine oxidase activity and schizophrenia
41. Reduced monoamine oxidase activity in platelets: A possible genetic marker for vulnerability to schizophrenia
42. Sensation seeking and cortical augmenting‐ reducing